Belgium: Ardena expands presence in Southern Europe with acquisition of Idifarma

Belgian pharmaceutical CDMO, Ardena, has acquired Idifarma, the Spanish contract manufacturer of niche and highly potent generic and innovative drugs, from Suanfarma and Sodena. The acquisition expands Ardena’s presence across Southern Europe and supports its strategy of becoming a leading global CDMO, offering integrated solutions across the full pharma development lifecycle. The acquisition brings the…

You must be a HMI Subscriber to view this content.

Subscribe Now »